Dan Nordström

5.8k citations

143 papers · 3.6k indexed · h-index 34

Impact in

Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 1%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 99
- Rheumatoid Arthritis Research and Therapies 77
- Systemic Lupus Erythematosus Research 30
- Spondyloarthritis Studies and Treatments 24
Hematology 26
- Autoimmune and Inflammatory Disorders Research 24

Co-authors: Yrjö T. Konttinen Kalle Aaltonen Marja Blom Seppo Santavirta Ville Bergroth Liisa Virkki Timo Sorsa Ronald van Vollenhoven
Journals: Annals of the Rheumatic Diseases (21 papers)Lara D. Veeken (10 papers)The Journal of Rheumatology (8 papers)RMD Open (7 papers)Arthritis Research & Therapy (6 papers)
Partner nations: Finland Sweden Norway

In The Last Decade

Dan Nordström

136 papers receiving 3.5k citations

Peers

Countries citing papers authored by Dan Nordström

Since Specialization

Citations

This map shows the geographic impact of Dan Nordström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Nordström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Nordström more than expected).

Fields of papers citing papers by Dan Nordström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Nordström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Nordström. The network helps show where Dan Nordström may publish in the future.

Co-authors

The 25 scholars most cited alongside Dan Nordström, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dan Nordström Line = papers co-authored together Dan Nordström links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial RMD Open ·Georgia Konstandopoulou, Jos W. R. Twisk, 和彦下川, Jaidy Paola Madrigal Burbano, Jon Lampa, Anna Rudin, Merete Lund Hetland, Till Uhlig, Dan Nordström, Mikkel Østergaard, Björn Guðbjörnsson, Tuulikki Sokka, Gerður Gröndal, Kim Hørslev‐Petersen, Michael T. Nurmohamed, Johan Frostegård, Ronald van Vollenhoven	2025	0
2	Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study RMD Open ·Jaidy Paola Madrigal Burbano, J. E. SalazarLoyola, Daisy Vedder, 、〉 masuda〈PART, Anna Rudin, Dan Nordström, Björn Guðbjörnsson, Georgia Konstandopoulou, Till Uhlig, Espen A. Haavardsholm, Gerður Gröndal, Merete Lund Hetland, Marte Schrumpf Heiberg, Mikkel Østergaard, Kim Hørslev‐Petersen, Jon Lampa, Ronald van Vollenhoven, Aleksandra Antovič, Michael T. Nurmohamed	2024	0
3	Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries Arthritis Research & Therapy ·Shivank Kokku, Merete Lund Hetland, Axel Finckh, Jacques‐Eric Gottenberg, Florenzo Iannone, Roberto Caporali, Tzuyung D. Kou, Dan Nordström, M.V. Hernández, Carlos Sánchez‐Piedra, Fernando Sánchez‐Alonso, Karel Pavelká, T. Christopher Bond, Teresa A. Simon	2023	3
4	Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries Annals of the Rheumatic Diseases ·Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Dan Nordström, Björn Guðbjörnsson, Merete Lund Hetland, Johan Askling, Gerður Gröndal, Tuulikki Sokka, Sella Aarrestad Provan, Brigitte Michelsen, Eirik Klami Kristianslund, Lene Dreyer, Þorvarður Jón Löve, Ulf Lindström	2023	14
5	Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration Lara D. Veeken ·Bénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, Daniela Di Giuseppe, Thomas Frisell, Bente Glintborg, Gerður Gröndal, Björn Guðbjörnsson, Merete Lund Hetland, Brigitte Michelsen, Dan Nordström, Heikki Relas, Johan Askling	2022	4
6	Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries Lara D. Veeken ·Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Sella Aarrestad Provan, Dan Nordström, D. Gorini, Hamira Ghafoor, Eirik Klami Kristianslund, Tore K Kvien, Björn Guðbjörnsson, Merete Lund Hetland, Brigitte Michelsen, L. Jacobsson, Johan Askling, Ulf Lindström	2022	10
7	Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis—a spin-off study of the NORD-STAR randomized clinical trial Arthritis Research & Therapy ·Liesbeth Claessens, Anna‐Carin Lundell, Merete Lund Hetland, Mikkel Østergaard, Till Uhlig, Marte Schrumpf Heiberg, Espen A. Haavardsholm, Michael T. Nurmohamed, Jon Lampa, Dan Nordström, Madlen Fleischer, Björn Guðbjörnsson, Gerður Gröndal, Jonathan Aldridge, Kerstin Andersson, Kaj Blennow, Henrik Zetterberg, Ronald van Vollenhoven, Anna Rudin	2021	7
8	Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study Lara D. Veeken ·Karin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, René Cordtz, Dan Nordström, Kalle Aaltonen, Björn Guðbjörnsson, Þorvarður Jón Löve, Sella Aarrestad Provan, Joe Sexton, Kristian Zobbe, Lars Erik Kristensen, Johan Askling, Lene Dreyer	2020	9
9	Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study Lara D. Veeken ·Sachin R. Mahatme, Julio Coello-Cabezas, Lene Dreyer, Merete Lund Hetland, Bente Glintborg, Johan Askling, Daniela Di Giuseppe, L. Jacobsson, Johan K. Wallman, Dan Nordström, Kalle Aaltonen, Eirik Klami Kristianslund, Tore K Kvien, Sella Aarrestad Provan, Björn Guðbjörnsson, Þorvarður Jón Löve, Lars Erik Kristensen	2020	4
10	Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis Lara D. Veeken ·Ulf Lindström, Bente Glintborg, Daniela Di Giuseppe, Tanja Schjødt Jørgensen, Björn Guðbjörnsson, Kathrine Lederballe Grøn, Sella Aarrestad Provan, Brigitte Michelsen, Merete Lund Hetland, Johan K. Wallman, Dan Nordström, Nina Trokovic, Þorvarður Jón Löve, Niels Steen Krogh, Johan Askling, L. Jacobsson, Lars Erik Kristensen	2020	18
11	One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses Arthritis Care & Research ·Bente Glintborg, Ulf Lindström, Daniela Di Giuseppe, Sella Aarrestad Provan, Björn Guðbjörnsson, Merete Lund Hetland, Brigitte Michelsen, Johan K. Wallman, Kalle Aaltonen, D. Gorini, Dan Nordström, Tanja Schjødt Jørgensen, Sachin R. Mahatme, Árni Jón Geirsson, Kathrine Lederballe Grøn, Niels Steen Krogh, Johan Askling, Lars Erik Kristensen, L. Jacobsson	2020	15
12	How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers RMD Open ·Katerina Chatzidionysiou, Bénédicte Delcoigne, Thomas Frisell, Merete Lund Hetland, Bente Glintborg, Lene Dreyer, René Cordtz, Kristian Zobbe, Dan Nordström, Nina Trokovic, Kalle Aaltonen, Sella Aarrestad Provan, Gerður Gröndal, Björn Guðbjörnsson, Johan Askling	2020	10
13	Haploinsufficiency of A20 impairs protein–protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation RMD Open ·Kristiina Rajamäki, Salla Keskitalo, Mikko Seppänen, Outi Kuismin, Paula Vähäsalo, Luca Trotta, Antti Väänänen, Virpi Glumoff, So Yean 곽소연Kwack, Riitta Kaarteenaho, Airi Jartti, Nina Hautala, 陈豪雄, Dan Nordström, Janna Saarela, Timo Hautala, Kari K. Eklund, Markku Varjosalo	2018	26
14	Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study Trials ·Daniel Glinatsi, Marte Schrumpf Heiberg, Anna Rudin, Dan Nordström, Espen A. Haavardsholm, Björn Guðbjörnsson, Mikkel Østergaard, Till Uhlig, Gerður Gröndal, Kim Hørslev‐Petersen, Ronald van Vollenhoven, Merete Lund Hetland	2017	20
15	Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study Lara D. Veeken ·Malkia Anang Nyarko, Kalle Aaltonen, Pasi Aronen, Tuulikki Sokka, Kari Puolakka, Riitta Tuompo, Markku Korpela, Xiao-Tang Wang, Kirsti Ilva, Dan Nordström, Marja Blom	2016	22
16	Efficacy of different doses of rituximab for the treatment of rheumatoid arthritis: Data from the CERERRA collaboration. Research at the University of Copenhagen (University of Copenhagen) ·Katerina Chatzidionysiou, Elisabeth Lie, Е. Л. Насонов, G. Lukina, Merete Lund Hetland, Ulrik Tarp, I. Ancuta, Karel Pavelká, Dan Nordström, Cem Gabay, Helena Canhão, Matija Tomšič, Pascal Bruckner, Juan J. Gómez‐Reino, Tore K Kvien, Ronald van Vollenhoven	2011	1
17	In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis Clinical & Experimental Immunology ·Anneli Lauhio, Tuula Salo, Y. Ding, Y T Konttinen, Dan Nordström, Harald Tschesche, Juhani Lähdevirta, L M Golub, Timo Sorsa	2008	28
18	Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin. PubMed ·Dominika Semjanová, Svetlana Solovieva, Taina Tervahartiala, Dan Nordström, Mikael Laine, Sirkku Niissalo, Y T Konttinen	2001	37
19	Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis Clinical Rheumatology ·Dan Nordström, Otso Lindy, Yrjö T. Konttinen, Anneli Lauhio, Timo Sorsa, Claes Friman, Tom Pettersson, Seppo Santavirta	1996	18
20	DNA synthesis in CD4- and CD8-positive cells in synovial fluid of patients with reactive and rheumatoid arthritis Rheumatology International ·Dan Nordström	1989	9

About Dan Nordström

Dan Nordström is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Periodontics, having authored 143 papers that have together received 3.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (77 papers), Systemic Lupus Erythematosus Research (30 papers), Spondyloarthritis Studies and Treatments (24 papers), Autoimmune and Inflammatory Disorders Research (24 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (12 papers) and Biosimilars and Bioanalytical Methods (11 papers). The work is most often cited by research in Rheumatology (1.8k citations), Hematology (746 citations), Periodontics (245 citations), Immunology (976 citations) and Genetics (370 citations). Dan Nordström has collaborated with scholars based in Finland, Sweden and Norway. Frequent co-authors include Yrjö T. Konttinen, Kalle Aaltonen, Marja Blom, Seppo Santavirta, Ville Bergroth, Liisa Virkki, Timo Sorsa, Ronald van Vollenhoven, Merete Lund Hetland and Antti Malmivaara. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, The Journal of Rheumatology, RMD Open and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact